Xenetic Biosciences, Inc.
XBIO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $2,500 | $2,540 | $1,707 | $1,161 |
| % Growth | -1.6% | 48.8% | 47.1% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $2,500 | $2,540 | $1,707 | $1,161 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $3,288 | $3,495 | $4,771 | $3,163 |
| G&A Expenses | $3,416 | $3,561 | $3,654 | $3,744 |
| SG&A Expenses | $3,416 | $3,561 | $3,654 | $3,744 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $6,705 | $7,056 | $8,425 | $6,907 |
| Operating Income | -$4,204 | -$4,516 | -$6,718 | -$5,747 |
| % Margin | -168.2% | -177.8% | -393.6% | -495.1% |
| Other Income/Exp. Net | $244 | $381 | $166 | $102 |
| Pre-Tax Income | -$3,960 | -$4,135 | -$6,552 | -$5,645 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$3,960 | -$4,135 | -$6,552 | -$5,645 |
| % Margin | -158.4% | -162.8% | -383.9% | -486.4% |
| EPS | -2.57 | -2.71 | -4.49 | -5.39 |
| % Growth | 5.2% | 39.6% | 16.7% | – |
| EPS Diluted | -2.57 | -2.71 | -4.49 | -5.39 |
| Weighted Avg Shares Out | 1,541 | 1,528 | 1,422 | 1,028 |
| Weighted Avg Shares Out Dil | 1,541 | 1,528 | 1,422 | 1,028 |
| Supplemental Information | – | – | – | – |
| Interest Income | $250 | $356 | $167 | $100 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $153 | $0 | $27 | $35 |
| EBITDA | -$4,051 | -$4,516 | -$6,691 | -$5,711 |
| % Margin | -162% | -177.8% | -392% | -492.1% |